Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area
CompletedOBSERVATIONAL
Enrollment
302
Participants
Timeline
Start Date
June 1, 2020
Primary Completion Date
November 1, 2020
Study Completion Date
May 1, 2021
Conditions
Coronary Syndrome
Trial Locations (1)
34295
Uhmontpellier, Montpellier
All Listed Sponsors
collaborator
Centre Hospitalier Universitaire de Nīmes
OTHER
lead
University Hospital, Montpellier
OTHER
NCT04881552 - Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area | Biotech Hunter | Biotech Hunter